Cleared Traditional

K023112 - PROSOLV CARDIVASCULAR VIEWER

Also marketed or referenced as:
ANALYZER SERVER VERSION 2.5.9

K023112 is an FDA 510(k) clearance for PROSOLV CARDIVASCULAR VIEWER, manufactured by Problem Solving Concepts, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K023112 · Problem Solving Concepts, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
89d
Days
Class 2
Risk

K023112 is an FDA 510(k) clearance for the PROSOLV CARDIVASCULAR VIEWER. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Problem Solving Concepts, Inc. (Indianapolis, US). The FDA issued a Cleared decision on December 17, 2002 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Problem Solving Concepts, Inc. devices

FDA 510(k) Submission Details - K023112

510(k) Number K023112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 2002
Decision Date December 17, 2002
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 330
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K023112.
CARDIOSOFT/CASE CARDIAC TESTING SYSTEM
K031561 · Ge Medical Systems Information Technologies · Aug 2003
LABSYSTEM III EP LABORATORY W/WINDOWS PLATFORM & WINDOWS EP SOFTWARE VERSION 1.0
K031000 · C.R. Bard, Inc. · Jun 2003
CARTO XP AND QWIKMAP EP NAVIGATION SYSTEM
K020863 · Biosense Webster, Inc. · Jan 2003
NEWCOR
K020440 · Siemens Medical Systems, Inc. · Dec 2002
T-WAVE ALTERMANS (TWA) ALGORITHM OPTION
K023380 · General Electric Medical Systems Information Techn · Dec 2002
RADIANALYZER, MODEL 12710
K022188 · Radi Medical Systems AB · Oct 2002